Caffeine's implications for women's health and survey of obstetrician-gynecologists' caffeine knowledge and assessment practices

Journal of Women's Health

Volumn 18, Issue 9, 2009, Pages 1457-1466

  Anderson, Britta L ^a,b   Juliano, Laura M ^b   Schulkin, Jay ^a  

^a AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS   (United States)

^b AMERICAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE;

ARTICLE; BREAST MILK; CLINICAL PRACTICE; COFFEE; DIETARY INTAKE; HEALTH CARE PERSONNEL; HUMAN; LOW BIRTH WEIGHT; MEDICAL SOCIETY; PATIENT EDUCATION; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; SPONTANEOUS ABORTION; STRUCTURED QUESTIONNAIRE;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COFFEE; FEMALE; GYNECOLOGY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; OBSTETRICS; PATIENT EDUCATION AS TOPIC; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; PRENATAL CARE; UNITED STATES;

EID: 70349208802     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.1186     Document Type: Article

References (59)

1. Frary CD, Johnson RK, Wang MQ. Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 2005;105:110-113.
2. Barone JJ, Roberts HR. Caffeine consumption. Food Chem Toxicol 1996;34:119-129.
3. Jacoby I, Meyer GS, Haffner W, et al. Modeling the future workforce of obstetrics and gynecology. Obstet Gynecol 1998;92:450-456.
4. Ferre S. An update on the mechanisms of the psychostimulant effects of caffeine. J Neurochem 17 Jan 2008.
5. Juliano LM, Ferre S, Griffiths RR. Caffeine: pharmacology and Clinical Effects. In: Graham AW, Schultz TK, Mayo-Smith M, et al., eds. Principles of Addiction Medicine 4th ed. Chevy Chase, MD: American Society of Addiciton Medicine; 2009 (in press).
6. Snel J. Coffee and caffeine: sleep and wakefulness. In: Garattini S, ed. Caffeine, Coffee, and Health. New York: Raven Press; 1993:255-290.
7. Greden JF. Anxiety or caffeinism: a diagnostic dilemma. Am J Psychiatry 1974;131:1089-1092.
8. Krystal AD. Insomnia in women. Clin Cornerstone 2003;5: 41-50.
9. Pigott TA. Gender differences in the epidemiology and treatment of anxiety disorders. J Clin Psychiatry 1999; 60(Suppl 18):4-15.
10. Vo HT, Smith BD, Elmi S. Menstrual endocrinology and pathology: caffeine, physiology, and PMS. In: Smith BD, Gupta U, Gupta BS, eds. Caffeine Activation Theory: Effects on Health and Behavior. Boca Raton, FL: Taylor & Francis Group; 2007:181-197.
11. Denaro CP, Benowitz NL. Caffeine metabolism: disposition in liver disease and hepatic-function testing. In: Watson RR, ed. Drug and Alcohol Abuse Reviews, Vol.2: Liver Pathology and Alcohol. Totowa, NJ: The Human Press; 1991:513-539.
12. Carrillo JA, Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 2000;39:127-153.
13. Parsons WD, Neims AH. Effect of smoking on caffeine clearance. Clin Pharmacol Ther 1978;24:40-45.
14. Aldridge A, Bailey J, Neims AH. The disposition of caffeine during and after pregnancy. Semin Perinatol 1981;5:310-314.
15. APA. Diagnostic and Statistical Manual of Mental Disorders, 4th ed [text revision]. Washington, DC: American Psychiatric Press, 2000.
16. Parsons WD, Neims AH. Prolonged half-life of caffeine in healthy term newborn infants. J Pediatr 1981;98:640-641.
17. Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl) 2004;176:1-29.
18. Svikis DS, Berger N, Haug NA, et al. Caffeine dependence in combination with a family history of alcoholism as a predictor of continued use of caffeine during pregnancy. Am J Psychiatry 2005;162:2344-2351.
19. Fennelly M, Galletly DC, Purdie GI. Is caffeine withdrawal the mechanism of postoperative headache? Anesth Analg 1991;72:449-453.
20. McGowan JD, Altman RE, Kanto WP, Jr. Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine. South Med J 1988;81:1092-1094.
21. Martin I, Lopez-Vilchez MA, Mur A, et al. Neonatal withdrawal syndrome after chronic maternal drinking of mate. Ther Drug Monit 2007;29:127-129.
22. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland: WHO, 1992.
23. Strain EC, Mumford G, Silverman K, et al. Caffeine dependence syndrome: evidence from case histories and experimental evaluations. JAMA 1994;272:1043-1048.
24. Juliano LM, Griffiths RR. Caffeine. In: Lowinson JH, Ruiz P, Millman RB, et al., eds. Substance Abuse: a Comprehensive Textbook, 4th ed. Baltimore, MD: Lippincott, Williams, & Wilkins; 2005:403-421.
25. Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007;357:1893-1902.
26. Shapiro RE. Caffeine and headaches. Neurol Sci 2007; 28(Suppl 2):S179-S183.
27. Sawynok J, Yaksh TL. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev 1993;45:43-85.
28. Ross GW, Abbott RD, Petrovitch H, et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 2000;283:2674-2679.
29. Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 2005;129:1928-1936.
30. van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005;294:97-104.
31. Lloyd T, Rollings N, Eggli DF, et al. Dietary caffeine intake and bone status of postmenopausal women. Am J Clin Nutr 1997;65:1826-1830.
32. Rapuri PB, Gallagher JC, Kinyamu HK, et al. Caffeine intake increases the rate of bone loss in elderly women and inter acts with vitamin D receptor genotypes. Am J Clin Nutr 2001;74:694-700.
33. Heyden S. Coffee and fibrocystic breast disease. Surgery 1980;88:741-742.
34. Heyden S, Fodor JG. Coffee consumption and fibrocystic breasts: An unlikely association. Can J Surg 1986;29:208-211.
35. Heyden S, Muhlbaier LH. Prospective study of "fibrocystic breast disease" and caffeine consumption. Surgery 1984;96: 479-484.
36. Ishitani K, Lin J, Manson JE, et al. Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med 2008;168:2022-2031.
37. Weng X, Odouli R, Li DK. Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Am J Obstet Gynecol 2008;198: e271-e278.
38. Fernandes O, Sabharwal M, Smiley T, et al. Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: a meta-analysis. Reprod Toxicol 1998;12:435-444.
39. Nawrot P, Jordan S, Eastwood J, et al. Effects of caffeine on human health. Food Addit Contam 2003;20:1-30.
40. Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 2006;46:101-123.
41. The Care Study Group. Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. BMJ 2008;337:a2332.
42. Grosso LM, Bracken MB. Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy. Ann Epidemiol 2005;15:460-466.
43. Sata F, Yamada H, Suzuki K, et al. Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss. Mol Hum Reprod 2005;11:357-360.
44. Health Canada. Caffeine and your health. Available at: www.hc-sc.gc.ca/fn-an/securit/facts-faits/caffeine-eng.php. Accessed August 30, 2008.
45. Kaiser L, Allen LH. Position of the American Dietetic Association: Nutrition and Lifestyle for a Pregnancy Outcome. J Am Diet Assoc 2008;108:553-561.
46. Food Standards Agency. COT statement on the reproductive effects of caffeine. Available at: http:cot.food.gov.uk/ cotstatements/cotstatementsyrs/ cotstatements2001/caffeine. Accessed August 30, 2008.
47. Hughes JR, Amori G, Hatsukami DK. A survey of physician advice about caffeine. J Subst Abuse 1988;1:67-70.
48. Aalto M, Hyvonen S, Seppa K. Do primary care physicians' own AUDIT scores predict their use of brief alcohol intervention? A cross-sectional survey. Drug Alcohol Depend 2006;83:169-173.
49. Bech BH, Nohr EA, Vaeth M, et al. Coffee and fetal death: a cohort study with prospective data. Am J Epidemiol 2005; 162:983-990.
50. Tolstrup JS, Kjaer SK, Munk C, et al. Does caffeine and alcohol intake before pregnancy predict the occurrence of spontaneous abortion? Hum Reprod 2003;18:2704-2710.
51. Rasch V. Cigarette, alcohol, and caffeine consumption: risk factors for spontaneous abortion. Acta Obstet Gynecol Scand 2003;82:182-188.
52. Management of Recurrent Early Pregnancy Loss. ACOG Practice Bulletin. Washington, DC: American College of Obstetricians and Gynecologists, 2001.
53. Bernstein GA, Carroll ME, Thuras PD, et al. Caffeine dependence in teenagers. Drug Alcohol Depend 2002;66: 1-6.
54. Diekman ST, Floyd RL, Decoufie P, et al. A survey of obstetrician- gynecologists on their patients' alcohol use during pregnancy. Obstet Gynecol 2000;95:756-763.
55. Price JH, Jordan TR, Dake JA. Obstetricians and gynecologists' perceptions and use of nicotine replacement therapy. J Commun Health 2006;31:160-175.
56. Bryant CM, Dowell CJ, Fairbrother G. Caffeine reduction education to improve urinary symptoms. Br J Nurs 2002;11: 560-565.
57. Bracken MB, Triche E, Grosso L, et al. Heterogeneity in assessing self-reports of caffeine exposure: implications for studies of health effects. Epidemiology 2002;13:165-171.
58. Hill LD, Erickson K, Holzman GB, et al. Practice trends in outpatient obstetrics and gynecology: findings of the Collaborative Ambulatory Research Network, 1995-2000. Obstet Gynecol Surv 2001;56:505-516.
59. Evans SM, Griffiths RR. Caffeine withdrawal: a parametric analysis of caffeine dosing conditions. J Pharmacol Exp Ther 1999;289:285-294.